Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

H2-M10.6 Inhibitors

H2-M10.6 inhibitors represent a distinct category of chemical compounds that have been designed to regulate the activity of the H2-M10.6 protein. H2-M10.6, also referred to as histocompatibility 2, M region locus 10.6, is a protein found within the major histocompatibility complex (MHC) system, a vital component of the immune system in mice. The MHC's primary function is to present antigenic peptides to T cells, enabling the immune system to identify and respond to foreign pathogens effectively. H2-M10.6, like other MHC molecules, plays a pivotal role in this process of antigen presentation, which is essential for initiating immune responses against infections. The development of H2-M10.6 inhibitors is centered around the objective of selectively interacting with the H2-M10.6 protein, potentially influencing its antigen-presenting activity and impacting immune recognition processes.

H2-M10.6 inhibitors typically comprise small molecules or chemical compounds that are purposefully engineered to bind to H2-M10.6, targeting either its active site or allosteric sites. This interaction has the potential to modify H2-M10.6's behavior, potentially affecting its ability to present antigenic peptides to T cells and, consequently, influencing the immune response against foreign antigens. Researchers are dedicated to unraveling the molecular mechanisms and functions of H2-M10.6 within the MHC system, aiming to gain insights into the complex immune recognition processes. The development of H2-M10.6 inhibitors represents an ongoing area of research within the fields of immunology and molecular pharmacology, contributing to a deeper understanding of the immune system's functioning and its role in detecting and responding to foreign antigens.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$176.00
$426.00
43
(3)

Intercalates into DNA, disrupting DNA and RNA synthesis which can lead to inhibited gene expression.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Binds tightly to DNA, inhibiting RNA polymerase and thus blocking RNA synthesis and gene expression.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

Inhibits RNA polymerase II, a critical enzyme in the transcription process, leading to reduced mRNA synthesis and gene expression.

Mitoxantrone

65271-80-9sc-207888
100 mg
$285.00
8
(1)

DNA intercalator and topoisomerase II inhibitor that can disrupt DNA replication and transcription, affecting gene expression.

Aphidicolin

38966-21-1sc-201535
sc-201535A
sc-201535B
1 mg
5 mg
25 mg
$84.00
$306.00
$1104.00
30
(3)

Inhibits DNA polymerase, leading to S phase arrest and potentially downregulating gene expression.

Cordycepin

73-03-0sc-203902
10 mg
$101.00
5
(1)

Terminates RNA chain elongation due to its similarity to adenosine but lack of a 3' hydroxyl group, reducing gene expression.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$97.00
$328.00
$676.00
$1467.00
6
(1)

Binds to bacterial RNA polymerase, inhibiting RNA synthesis. In eukaryotes, it could affect mitochondrial gene expression.

Novobiocin

303-81-1sc-362034
sc-362034A
5 mg
25 mg
$128.00
$380.00
(0)

Targets DNA gyrase in bacteria and can affect topoisomerases in eukaryotic cells, potentially decreasing gene expression.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Binds to DNA and prevents binding of transcription factors, particularly to G-C rich regions, downregulating gene expression.